Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

efficacy

  • Open Access
    Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
    YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
  • Open Access
    Meckel’s Diverticulum Carcinoma Is Arrested by Oxaliplatinum and Eradicated by 5-Fluorouracil in a PDX Mouse Model Indicating Candidate First-line Treatment for a Rare Cancer
    NORIYUKI MASAKI, YUTAKA YONEMURA, CHIHIRO HOZUMI, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI and ROBERT M. HOFFMAN
    In Vivo July 2023, 37 (4) 1482-1485; DOI: https://doi.org/10.21873/invivo.13232
  • Open Access
    Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece
    VASILIKI RAPTI, MARIA-EFFROSYNI LIVANOU, ANASTASIOS KOLLIAS, TILEMACHOS KOUTOURATSAS, ORESTIS SAVRANAKIS, VISSARIA SAKKA, THOMAS NITSOTOLIS, ELENI KAKALOU, KALOMOIRA ATHANASIOU, KONSTANTINOS N. SYRIGOS and GARYFALLIA POULAKOU
    In Vivo May 2023, 37 (3) 1312-1317; DOI: https://doi.org/10.21873/invivo.13210
  • Open Access
    Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model
    NORIYUKI MASAKI, QINGHONG HAN, NATHANIEL F. WU, CARISSA SAMONTE, JUSTIN WU, CHIHIRO HOZUMI, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI, JUN MIYAZAKI and ROBERT M. HOFFMAN
    In Vivo November 2022, 36 (6) 2598-2603; DOI: https://doi.org/10.21873/invivo.12994
  • Open Access
    A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic Chemotherapy
    EIKI YAMASAKI, FUKUTARO SHIMAMOTO, HIROKI NISHIKAWA, MASAHIRO GOTO, MITSUHIKO IWAMOTO, KOSEI KIMURA, AKIRA UKIMURA, NAOFUMI OOSAKA, KOHEI TANIGUCHI, FUMIHITO ONO, TETSUJI TERAZAWA, TOSHIFUMI YAMAGUCHI, KEN ASAISHI, TAKAKO IKEGAMI, KAZUHISA UCHIYAMA, SHIRO NAKAMURA and KAZUHIDE HIGUCHI
    In Vivo November 2022, 36 (6) 2780-2789; DOI: https://doi.org/10.21873/invivo.13015
  • You have access
    Salmonella typhimurium A1-R Exquisitely Targets and Arrests a Matrix-producing Triple-negative Breast Carcinoma in a PDOX Model
    KAZUYUKI HAMADA, YUSUKE AOKI, JUN YAMAMOTO, CHIHIRO HOZUMI, MING ZHAO, TAKUYA MURATA, NORIHIKO SUGISAWA, MICHAEL BOUVET, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo November 2021, 35 (6) 3067-3071; DOI: https://doi.org/10.21873/invivo.12602
  • You have access
    Osteosarcoma of the Breast in a Patient Derived Orthotopic Xenograft (PDOX) Mouse Model Is Arrested by both Cisplatinum and Eribulin
    NORIYUKI MASAKI, NATHANIEL F. WU, YUSUKE AOKI, JUN YAMAMOTO, JUN MIYAZAKI and ROBERT M. HOFFMAN
    In Vivo November 2021, 35 (6) 3107-3110; DOI: https://doi.org/10.21873/invivo.12605
  • You have access
    Traditional Chinese Medicine Brucea Javanica Oil Enhances the Efficacy of Anlotinib in a Mouse Model of Liver-Metastasis of Small-cell Lung Cancer
    SONG PENG, WENHONG DONG, QIANGQIANG CHU, JIA MENG, HAITAO YANG, YINGYING DU, YU SUN and ROBERT M. HOFFMAN
    In Vivo May 2021, 35 (3) 1437-1441; DOI: https://doi.org/10.21873/invivo.12395
  • You have access
    Bevacizumab Efficacy and Recurrence Pattern of Persistent and Metastatic Cervical Cancer
    NARA LEE, SE IK KIM, MARIA LEE, HEE SEUNG KIM, JAE WEON KIM, NOH HYUN PARK and YONG SANG SONG
    In Vivo May 2019, 33 (3) 863-868; DOI: https://doi.org/10.21873/invivo.11551
  • You have access
    Characteristics and Outcomes of Extreme Elderly Patients With Hepatocellular Carcinoma in South Korea
    JI HO SEO, DONG HYUN KIM, EUNAE CHO, CHUNG HWAN JUN, SEON YOUNG PARK, SUNG BUM CHO, CHANG HWAN PARK, HYUN SOO KIM, SUNG KYU CHOI and JONG SUN REW
    In Vivo January 2019, 33 (1) 145-154; DOI: https://doi.org/10.21873/invivo.11451

Pages

  • Next
  • 1
  • 2
In Vivo

© 2023 In Vivo

Powered by HighWire